Data as of May 17
| +0.18 / +0.38%|
The 17 analysts offering 12-month price forecasts for St. Jude Medical Inc have a median target of 46.00, with a high estimate of 54.00 and a low estimate of 34.00. The median estimate represents a -2.13% decrease from the last price of 47.00.
The current consensus among 25 polled investment analysts is to Buy stock in St. Jude Medical Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.